Purdue Pharma, OxyContin and bankruptcy judge
Digest more
The Sackler family, owners of OxyContin maker Purdue Pharma, has agreed to pay $6 billion to settle long-running litigation alleging they fueled the nation’s opioid epidemic, The New York Times ...
The $7.4 billion settlement plan proposed by OxyContin maker Purdue Pharma and the Sackler family members who own the bankrupt firm has gained nearly unanimous creditor approval. More than ...
OxyContin maker Purdue Pharma and a group of states have not been able to agree on a multibillion-dollar settlement of lawsuits over the drug’s role in the opioid crisis after more than a month ...
The Sackler Family will pull out of Purdue Pharma’s bankruptcy plan, which has been negotiated for two years and pledges $4.5 billion to combat the opioid epidemic, unless they are granted ...
Purdue Pharma's reorganization plan received overwhelming support from voting creditors, clearing a hurdle in the company's effort to settle thousands of lawsuits tied to the opioid epidemic.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results